Ledger.Open graph →
SEC Form D · filed April 21, 2022

Dianthus Therapeutics, Inc

Offering
$100.0M
Sold
$100.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Tomas E. Kiselak · Waltham, MADirectorKenneth E. Thompson · Waltham, MAExecJonathan E. Violin · Waltham, MADirectorLeon O. Moulder, Jr · Waltham, MADirectorPaula E. Soteropoulos · Peabody, MADirectorLei E. Meng · Greenwich, CTDirectorMatthew Topliff · Malvern, PADirectorJason Keiser · Malvern, PADirectorWinifred Walters · Flagler, COExecJoni Creighton · Flagler, CODirectorMarino Garcia · Waltham, MAExec · DirectorRoss Buhrdorf · Austin, TXDirectorJenne Britell · Austin, TXDirectorPorter Lummus · Atlanta, GADirectorStephen D. Reynolds · Coral Gables, FLExecPaula E. Soteropoulos · Peabody, MADirectorLei E. Meng · Greenwich, CTDirectorMarino Garcia · Waltham, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗